Trials / Terminated
TerminatedNCT02316847
An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.
Multi-center, Open-label, Study of Safety and Tolerability of Chronic Intermittent Usage of Diazepam Nasal Spray in Adolescents and Adult Patients With Cluster Seizures, Including Assessment of Olfaction and Reported Changes in Taste.
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 126 (actual)
- Sponsor
- Acorda Therapeutics · Industry
- Sex
- All
- Age
- 12 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess long-term safety and tolerability of repeat dose diazepam nasal spray in adolescents and adults with cluster seizures, with a focus on potential local effects (changes in nasal mucosa, olfaction, and taste).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | diazepam nasal spray |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2016-07-01
- Completion
- 2016-09-01
- First posted
- 2014-12-15
- Last updated
- 2018-07-30
- Results posted
- 2018-07-30
Locations
33 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02316847. Inclusion in this directory is not an endorsement.